The positive ratings from HC Wainwright and Wedbush have led to an increase in the trading price of MoonLake Immunotherapeutics' shares. This reaffirmation of positive ratings indicates a strong confidence in the company's performance, which is likely to attract more investors, thus driving the stock price up in the short term.